Abstract
Bariatric surgery should be considered in the management of adult patients (age range 18–60 years) with severe obesity (BMI >40 kg/m2 or BMI >35 kg/m2 with comorbid conditions) who failed to lose weight or to maintain long-term weight loss, despite appropriate nonsurgical medical care, and are willing to participate in a postoperative long-term follow-up program. (Level of evidence II, Strength of recommendation A)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gastrointestinal surgery for severe obesity (1991) National Institutes of Health Consensus Development Conference draft Statement. Obes Surg 1:257–266
American College of Cardiology/American Heart Association Task Force on Practice Guidelines/Obesity Expert Panel (2014) Executive Summary: guidelines (2013) for the management of overweight and obesity in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.
National Institute for Health and Clinical Excellence. Obesity: identification, assessment and management of overweight and obesity in children, young people and adults. NICE clinical guideline 189. Nov 2014
Fried M, Yumuk V, Oppert JM et al (2014) on behalf of International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter (IFSO-EC) and European Association for the Study of Obesity (EASO). Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery. Obes Surg 24:42–55
Società Italiana di Chirurgia dell’Obesità e delle malattie metaboliche (2006) Linee guida e stato dell’arte della chirurgia bariatrica e metabolica in Italia. SICOB 1–87
Sjöström L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med 273:219–234
Sjöström L, Narbro K, Sjöström CD et al (2007) Swedish Obese Subjects Study: Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752
MacDonald KG Jr, Long SD, Swanson MS et al (1997) The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1:213–220
Christou NV, Sampalis JS, Liberman M et al (2004) Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240:416–423
Adams TD, Gress RE, Smith SC et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761
Busetto L, Mirabelli D, Petroni ML et al (2007) Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis 3:496–502
Peeters A, O’Brien PE, Laurie C et al (2007) Substantial intentional weight loss and mortality in the severely obese. Ann Surg 246:1028–1033
Pontiroli AE, Morabito A (2011) Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 253:1–4
Dixon JB, O’Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323
Schauer PR, Bhatt DL, Kirwan JP et al (2014) Bariatric surgery versus intensive medical therapy for diabetes – 3-Year outcomes. N Engl J Med 370:2002–2013
Mingrone G, Panunzi S, De Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366:1577–1585
Ikramuddin S, Korner J, Lee WJ et al (2013) Roux-en-Y Gastric Bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. The Diabetes Surgery Study randomized clinical trial. JAMA 309:2240–2249
Busetto L, Cerbone MR, Lippi C, Micanti F, Sampietro S. Società Italiana di Chirurgia dell’Obesità e delle Malattie Metaboliche (2011) Suggerimenti per la valutazione psicologico-psichiatrica del paziente obeso candidato alla chirurgia bariatrica. SICOb
Inge TH, Krebs NF, Garcia VF et al (2004) Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 114:217–223
Pratt JSA, Lenders CM, Dionne EA et al (2009) Best practice updates for pediatric/adolescent weight loss surgery. Obesity 17:901–910
O’Brien PE, Sawyer SM, Laurie C et al (2010) Laparoscopic adjustable gastric banding in severely obese adolescents. A randomized trial. JAMA 303:519–526
Sugerman HJ, DeMaria EJ, Kellum JM et al (2004) Effects of bariatric surgery in older patients. Ann Surg 240:243–247
Quebbemann B, Engstrom D, Siegfried T et al (2005) Bariatric surgery in patients older than 65 years is safe and effective. Surg Obes Relat Dis 1:389–392
Hazzan D, Chin EH, Steinhagen E et al (2006) Laparoscopic bariatric surgery can be safe for treatment of morbid obesity in patients older than 60 years. Surg Obes Relat Dis 2:613–616
Taylor CJ, Layani L (2006) Laparoscopic adjustable gastric banding in patients > or = 60 years old: is it worthwhile? Obes Surg 16:1579–1583
Dunkle-Blatter SE, St Jean MR, Whitehead C et al (2007) Outcomes among elderly bariatric patients at a high-volume center. Surg Obes Relat Dis 3:163–169
Busetto L, Angrisani L, Basso N et al (2008) Safety and efficacy of laparoscopic adjustable gastric banding in the elderly. Obesity 16:334–338
Villareal DT, Apovian CM, Kushner RF, Klein S (2005) Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr 82:923–934
O’Brien PE, Dixon JB, Laurie C et al (2006) Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. A randomized trial. Ann Intern Med 144:625–633
Li Q, Chen L, Yang Z et al (2012) Metabolic effects of bariatric surgery in type 2 diabetic patients with bodymass index of 35 kg/m2. Diabetes Obes Metab 14:262–270
Reis CEG, Alvarez-Leite JI, Bressan J et al (2012) Role of bariatric–metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther 14:365–372
Scopinaro N, Adami GF, Papadia FS et al (2011) The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): A prospective controlled study. Obes Surg 21:880–888
American Diabetes Association (2014) Standards of medical care in diabetes – 2014. Diabetes Care 37:S14–S80
Dixon JB, Zimmet P, Alberti KG et al (2011) Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med 28:628–642
Mechanick JI, Youdim A, Jones DB et al (2013) Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic and Bariatric Surgery. Surg Obes Relat Dis 9:159–191
Clinical Issues Committee ASMBS (2013) Bariatric surgery in class I obesity (BMI 30–35 kg/m2). Surg Obes Relat Dis 9:e1–e10
Busetto L, Dixon J, De Luca M, Shikora S, Pories W, Angrisani L (2014) Bariatric surgery in class I obesity. A position statement from the International Federation for the Surgery of Obesity and metabolic disorders (IFSO). Obes Surg 24:487–519
Ferraro DR (2004) Preparing patients for bariatric surgery-the clinical considerations. Clin Rev 14:57–63
Kelly J, Tarnoff M, Shikora S et al (2005) Best practice recommendations for surgical care in weight loss surgery. Obes Res 13:227–233
Saltzman E, Anderson W, Apovian CM et al (2005) Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res 13:234–243
Heber D, Greenway FL, Kaplan LM et al (2010) Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 95:4823–4843
Mechanick JI, Kushner RF, Sugerman HJ et al (2009) American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity 17:S1–S70
Tariq N, Chand B (2011) Presurgical evaluation and postoperative care for the bariatric patient. Gastrointest Endosc Clin N Am 21:229–240
Fierabracci P, Pinchera A, Martinelli S et al (2011) Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg 21:54–60
Sauerland S, Angrisani L, Belachew M et al (2005) European Association for Endoscopic Surgery: Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 19:200–221
Dahl JK, Eriksen L, Vedul-Kjelsås E et al (2010) Prevalence of all relevant eating disorders in patients waiting for bariatric surgery: a comparison between patients with and without eating disorders. Eat Weight Disord 15:e247–e255
Piaggi P, Lippi C, Fierabracci P, Maffei M, Calderone A, Mauri M, Anselmino M, Cassano GB, Vitti P, Pinchera A, Landi A, Santini F (2010) Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women. PLoS One 5:e13624
Pull CB (2010) Current psychological assessment practices in obesity surgery programs: what to assess and why. Curr Opin Psychiatry 23:30–36
Fris RJ (2004) Preoperative low energy diet diminishes liver size. Obes Surg 14:1165–1170
Edholm D, Kullberg J, Haenni A et al (2011) Preoperative 4-week low- calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg 21:345–350
Lewis MC, Phillips ML, Slavotinek JP et al (2006) Change in liver size and fat content after treatment with Optifast® Very Low Calorie Diet. Obes Surg 16:697–701
Frutos MD, Morales MD, Luján J et al (2007) Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass. Obes Surg 17:150–154
Busetto L, Enzi G, Inelmen EM et al (2005) Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. Chest 128:618–623
Busetto L, Segato G, De Luca M et al (2004) Pre-operative weight loss by intragastric balloon in super obese patients treated with laparoscopic gastric banding: a Case-control study. Obes Surg 14:671–676
Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:338S–400S
Gonzalez QH, Tishler DS, Plata-Munoz JJ et al (2004) Incidence of clinically evident deep venous thrombosis after laparoscopic Roux en-Y gastric bypass. Surg Endosc 18:1082–1084
Forestieri P, Quarto G, De Caterina M et al (2007) Prophylaxis of thromboembolism in bariatric surgery with parnaparin. Obes Surg 17:1558–1562
Wurtz R, Itokazu G, Rodvold K (1997) Antimicrobial dosing in obese patients. Clin Infect Dis 25:112–118
Pai MP, Bearden DT (2007) Antimicrobial dosing considerations in obese adult patients. Pharmacotherapy 27:1081–1091
Parikh MS, Laker S, Weiner M, Hajiseyedjavadi O, Ren CJ (2006) Objective comparison of complications resulting from laparoscopic bariatric procedures. J Am Coll Surg 202:252–261
Chapman AE, Kiroff G, Game P et al (2004) Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 135:326–351
Chevallier JM, Zinzindohoue F, Douard R et al (2004) Complications after laparoscopic adjustable gastric banding for morbid obesity: experience with 1,000 patients over 7 years. Obes Surg 14:407–414
Ponce J, Paynter S, Fromm R (2005) Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg 201:529–535
O’Brien PE, McPhail T, Chaston TB, Dixon JB (2006) Systematic review of medium-term weight loss after bariatric operations. Obes Surg 16:1032–1040
Favretti F, Ashton D, Busetto L, Segato G, De Luca M (2009) The gastric band: first-choice procedure for obesity surgery. World J Surg 33:2039–2048
Morino M, Toppino M, Bonnet G, Rosa R, Garrone C (2002) Laparoscopic vertical banded gastroplasty for morbid obesity. Assessment of efficacy. Surg Endosc 16:1566–1572
Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13:861–864
Silecchia G, Boru C, Pecchia A et al (2006) Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg 16:1138–1144
Himpens J, Dapri G, Cadiere GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456
Braghetto I, Korn O, Valladares H et al (2007) Laparoscopic sleeve gastrectomy: surgical technique, indications and clinical results. Obes Surg 17:1442–1450
Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 25:319–324
Wittgrove AC, Clark GW (2000) Laparoscopic gastric bypass, Roux en-Y, 500 patients: technique and results with 3–60 months follow-up. Obes Surg 10:233–239
Higa KD, Boone KB, Ho T, Davies OG (2000) Laparoscopic Roux-en-Y gastric-bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg 135:1029–1033
Nguyen NT, Rivers R, Wolfe BM (2003) Factors associated with operative outcomes in laparoscopic gastric bypass. J Am Coll Surg 197:548–555
Schauer PR, Burguera B, Ikramuddin S et al (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–485
Rutledge R (2001) The mini-gastric bypass: experience with the first 1272 cases. Obes Surg 11:276–280
Lee WJ, Ser KH, Lee YC (2012) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg 22:1827–1834
Kim Z, Hur KY (2011) Laparoscopic Mini Gastric Bypass for type 2 diabetes: the preliminary report. World J Surg 35:631–636
Caballero M, Carbajo M (2004) One Anastomosis Gastric Bypass: a simple, safe and efficient surgical procedure for treating morbid obesity. Nutr Hosp 19:372–375
Noun R, Zeidan S, Riachi E (2007) Mini Gastric Bypass for revision of failed primary restrictive procedures: a valuable option. Obes Surg 17:684–688
Chevallier JM, Chakhtoura G, Zinzindohouè F (2009) Laparoscopic mini gastric bypass. J Chir 146:60–64
Musella M, Susa A, Greco F, De Luca M, Manno E, Di Stefano C (2014) The laparoscopic mini-gastric bypass: the italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc 28:156–163
Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V (1979) Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 66:618–620
Scopinaro N, Gianetta E, Adami GF et al (1996) Biliopancreatic diversion for obesity at eighteen years. Surgery 119:261–268
Scopinaro N, Marinari GM, Camerini G (2002) Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg 12:362–365
Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF (2005) Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a longterm follow-up study. Diabetes Care 28:2406–2411
Marinari GM, Papadia FS, Briatore L, Adami G, Scopinaro N (2006) Type 2 diabetes and weight loss following biliopancreatic diversion for obesity. Obes Surg 16:1440–1444
Scopinaro N, Papadia F, Marinari G, Camerini G, Adami G (2007) Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. Obes Surg 17:185–192
Marceau P, Hould FS, Simard S et al (1998) Biliopancreatic diversion with duodenal switch. World J Surg 22:947–954
Hess DS, Hess DW (1998) Biliopancreatic diversion with a duodenal switch. Obes Surg 8:267–282
Gagner M (2004) Laparoscopic biliopancreatic diversion with duodenal switch. Laparoscopic Bariatric Surgery. Lippincott Williams & Wilkins, Philadelphia, pp 133–142
Doldi SB, Lattuada E, Zappa MA et al (1998) Biliointestinal bypass: another surgical option. Obes Surg 8:566–570
Cariani S, Amenta E (2007) Three-year results of Roux-en-Y gastric bypass-on-vertical banded gastroplasty: an effective and safe procedure which enables endoscopy and X-ray study of the stomach and biliary tract. Obes Surg 17:1312–1318
Furbetta F, Gambinotti G (2002) Functional gastric bypass with an adjustable gastric band. Obes Surg 12:876–880
Vassallo C, Berbiglia G, Pessina A et al (2007) The Super-Magenstrasse and Mill operation with pyloroplasty: preliminary results. Obes Surg 17:1080–1083
Sánchez-Pernaute A, Herrera MA, Pérez-Aguirre ME et al (2010) Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obes Surg 20:1720–1726
Talebpour M, Amoli BS (2007) Laparoscopic total gastric vertical plication in morbid obesity. J Laparoendosc Adv Surg Tech A 17:793–798
de Jong K, Mathus-Vliegen EM, Veldhuyzen EA, Eshuis JH, Fockens P (2010) Short-term safety and efficacy of the Trans-oral Endoscopic Restrictive Implant System for the treatment of obesity. Gastrointest Endosc 72:497–504
Schouten R, Rijs CS, Bouvy ND et al (2010) A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 251:236–243
De Luca M, Segato G, Busetto L et al (2004) Progress in implantable gastric stimulation: summary of results of the European multi-center study. Obes Surg 14:S33–S39
Sanmiguel CP, Conklin JL, Cunneen SA et al (2009) Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control. J Diabetes Sci Technol 3:964–970
Ikramuddin S, Blackstone RP, Brancatisano A et al (2014) Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA 312:915–922
Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F (2007) Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients withBMI 22–34: a report of two cases. Surg Obes Relat Dis 3:195–197
Ramos AC, Galvao Neto MP, de Souza YM et al (2009) Laparoscopic duodenaljejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI <30 kg/m2. Obes Surg 19:307–312
De Paula AL, Stival AR, Macedo A et al (2010) Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21–34 kg/m(2). Surg Obes Relat Dis 6:296–304
Tacchino RM, Greco F, Matera D, Diflumeri G (2010) Single-incision laparoscopic gastric bypass for morbid obesity. Obes Surg 20:1154–1160
Parini U, Fabozzi M, Brachet Contul R et al (2006) Laparoscopic gastric bypass performed with the Da Vinci Intuitive Robotic System: preliminary experience. Surg Endosc 20:1851–1857
De Luca M, de Werra C, Formato A et al (2000) Laparotomic vs laparoscopic lap-band: 4-year results with early and intermediate complications. Obes Surg 10:266–268
Davila-Cervantes A, Borunda D, Dominguez-Cherit G et al (2002) Open versus laparoscopic vertical banded gastroplasty: a randomized controlled double blind trial. Obes Surg 12:812–818
Kim WW, Gagner M, Kini S et al (2003) Laparoscopic vs. open biliopancreatic diversion with duodenal switch: a comparative study. J Gastrointest Surg 7:552–557
Lujan JA, Frutos MD, Hernandez Q et al (2004) Laparoscopic versus open gastric bypass in the treatment of morbid obesity: a randomized prospective study. Ann Surg 239:433–437
Hutter MM, Randall S, Khuri SF et al (2006) Laparoscopic versus open gastric bypass for morbid obesity. A multicenter, prospective, risk-adjusted analysis from the national surgical quality improvement program. Ann Surg 243:657–666
Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB (2009) A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg 250:631–641
Genco A, Cipriano M, Bacci V et al (2006) Bioenterics Intragastric Balloon: a short term, double blind, randomized, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes 30:129–133
Genco A, Bruni T, Doldi SB et al (2005) BioEnterics Intragastric Balloon: The Italian experience with 2,515 patients. Obes Surg 15:1161–1164
Mathus-Vliegen EM, Tytgat GN (2005) Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 61:19–27
Ziegler O, Sirveaux MA, Brunaud L, Reibel N, Quilliot D (2009) Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab 35:544–557
Buhmann H, Vines L, Schiesser M (2014) Operative strategies for patients with failed primary bariatric procedures. Dig Surg 31:60–66
Brethauer SA, Kothari S, Sudan R et al (2014) Systematic review on reoperative bariatric surgery: American Society for Metabolic and Bariatric Surgery Revision Task Force. Surg Obes Relat Dis 10:952–972
Lannoo M, Dillemans B (2014) Laparoscopy for primary and secondary bariatric procedures. Best Pract Res Clin Gastroenterol 28:159–173
Kellogg TA (2011) Revisional bariatric surgery. Surg Clin North Am 91:1353–1371
Busetto L, Segato G, De Marchi F, Foletto M, De Luca M, Favretti F, Enzi G (2003) Postoperative management of laparoscopic gastric banding. Obes Surg 13:121–127
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Busetto, L., Angrisani, L., De Luca, M., Forestieri, P., Millo, P., Santini, F. (2016). Bariatric Surgery. In: Sbraccia, P., Nisoli, E., Vettor, R. (eds) Clinical Management of Overweight and Obesity. Springer, Cham. https://doi.org/10.1007/978-3-319-24532-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-24532-4_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24530-0
Online ISBN: 978-3-319-24532-4
eBook Packages: MedicineMedicine (R0)